LifeView

Article

LifeView is a recurring organization in the Astral Codex Ten archive, appearing 3 times across 3 issues between July 01, 2021 and December 11, 2023. The archive places it in contexts such as “LifeView, the company that handled the screening”; “LifeView, the pioneering polygenic screening company, has some helpful calculators”; “The polygenic embryo selection product exists and is available through LifeView”. It most often appears alongside 2020 election, 2020 primary, 23andme.

Metadata

  • Category: Organizations
  • Mention count: 3
  • Issue count: 3
  • First seen: July 01, 2021
  • Last seen: December 11, 2023

Appears In

Source Context

Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.

July 01, 2021 · Original source
[conflict of interest notice: LifeView, the company that handled the screening, was co-founded by Steve Hsu. I’ve known Steve for many years now, he is very nice to me, always patiently answers my genetics questions, and sometimes comes to SSC/ACX meetups]
I often have patients ask me something like: "I have a history of schizophrenia in my family. I'm really concerned my kid might get schizophrenia. What can I do to prevent this?" Right now I don't have a lot of answers, besides just staying generally healthy during pregnancy and making sure the kid has a healthy upbringing. But with polygenic screening, you start to get more options. You can IVF lots of embryos, test all of them for genetic schizophrenia risk, and implant whichever one gets the lowest score. How much does that help? LifeView, the pioneering polygenic screening company, has some helpful calculators:
February 20, 2023 · Original source
The polygenic embyro selection product exists and is available through LifeView. I can’t remember whether I knew about them in 2018 or whether this was a good prediction.
December 11, 2023 · Original source
2: A few years ago I wrote about embryo screening, where people doing IVF with multiple embryos could determine which embryo had the healthiest genes and implant that one. That post focused on a the company called LifeView, mostly because they were the only ones offering the service at the time. Now new company Orchid Health wants me to mention that they are also offering this service. They claim to screen for more rare single-gene disorders than LifeView, as well as the usual polygenic screening for common problems like diabetes, obesity, and Alzheimers (although they may also be more expensive). Their Science and Clinician pages have more information, and their signup link is here.